The National Covid Cohort Collaborative is open for research

By |2020-09-11T12:43:55-04:00September 9th, 2020|

In this podcast, Melissa Haendel, Director at CD2H and Christopher Chute Co-Director at CD2H discuss the key goals of the N3C initiative and its unique value proposition. The podcast provides insights into how this collaborative effort brings together experts with knowledge, skills, and experience to address this urgent public health issue. The podcast outlines the scope, opportunities, and challenges of N3C association with the commercial groups such as pharma & med-devices. It also touches upon the various roadblocks faced by the team in their journey so far. [Read more]

Thoughts on Advanced Real-World Data and Rare Diseases

By |2020-08-19T11:29:07-04:00August 17th, 2020|

"There are approximately 7,000 recognized rare diseases Estimates indicate that rare diseases affect over 350 million people worldwide ~ 1 in 10 people in the United States."  - FDA Rare Diseases: 2019 Guidance for Industry OVERVIEW: UNMET NEED AND OPPORTUNITY Advancements in personalized medicine via innovative data and analytic solutions continue to accelerate [Read more]